Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells

Gunnarsdóttir, Frida Björk LU ; Hagerling, Catharina LU ; Bergenfelz, Caroline LU orcid ; Mehmeti, Meliha LU ; Källberg, Eva LU ; Allaoui, Roni LU ; Mohlin, Sofie LU orcid ; Påhlman, Sven LU ; Larsson, Christer LU and Jirström, Karin LU orcid , et al. (2020) In Experimental Cell Research 390(1).
Abstract

Patients with estrogen receptor α positive (ERα+) breast cancer can respond to endocrine therapy, but treatment resistance is common and associated with downregulation of ERα expression in the dormant residual cells. Here we show, using long-term NSG xenograft models of human breast cancer and primary human monocytes, in vitro primary cell cultures and tumors from breast cancer patients, that macrophage derived tumor necrosis factor alpha (TNFα) downregulates ERα in breast cancer cells via inactivation of the transcription factor Forkhead box O transcription factor 3a (FOXO3a). Moreover, presence of tumor associated macrophages in the primary tumor of breast cancer patients, was associated with ERα negativity, and with worse... (More)

Patients with estrogen receptor α positive (ERα+) breast cancer can respond to endocrine therapy, but treatment resistance is common and associated with downregulation of ERα expression in the dormant residual cells. Here we show, using long-term NSG xenograft models of human breast cancer and primary human monocytes, in vitro primary cell cultures and tumors from breast cancer patients, that macrophage derived tumor necrosis factor alpha (TNFα) downregulates ERα in breast cancer cells via inactivation of the transcription factor Forkhead box O transcription factor 3a (FOXO3a). Moreover, presence of tumor associated macrophages in the primary tumor of breast cancer patients, was associated with ERα negativity, and with worse prognosis in patients with ERα+ tumors. We propose that pro-inflammatory macrophages, despite being tumoricidal, may have direct effects on tumor progression and endocrine resistance in breast cancer patients. Our findings suggest that TNFα antagonists should be evaluated for treatment of ERα+ breast cancer.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Breast cancer, Endocrine resistance, Estrogen receptor, FOXO3a, Macrophage, TNFalpha
in
Experimental Cell Research
volume
390
issue
1
article number
111932
publisher
Academic Press
external identifiers
  • scopus:85081264612
  • pmid:32145253
ISSN
0014-4827
DOI
10.1016/j.yexcr.2020.111932
language
English
LU publication?
yes
id
d3e5fa97-2648-401d-a2c4-ec6e3e233131
date added to LUP
2020-04-07 16:38:56
date last changed
2024-03-04 16:28:43
@article{d3e5fa97-2648-401d-a2c4-ec6e3e233131,
  abstract     = {{<p>Patients with estrogen receptor α positive (ERα<sup>+</sup>) breast cancer can respond to endocrine therapy, but treatment resistance is common and associated with downregulation of ERα expression in the dormant residual cells. Here we show, using long-term NSG xenograft models of human breast cancer and primary human monocytes, in vitro primary cell cultures and tumors from breast cancer patients, that macrophage derived tumor necrosis factor alpha (TNFα) downregulates ERα in breast cancer cells via inactivation of the transcription factor Forkhead box O transcription factor 3a (FOXO3a). Moreover, presence of tumor associated macrophages in the primary tumor of breast cancer patients, was associated with ERα negativity, and with worse prognosis in patients with ERα<sup>+</sup> tumors. We propose that pro-inflammatory macrophages, despite being tumoricidal, may have direct effects on tumor progression and endocrine resistance in breast cancer patients. Our findings suggest that TNFα antagonists should be evaluated for treatment of ERα<sup>+</sup> breast cancer.</p>}},
  author       = {{Gunnarsdóttir, Frida Björk and Hagerling, Catharina and Bergenfelz, Caroline and Mehmeti, Meliha and Källberg, Eva and Allaoui, Roni and Mohlin, Sofie and Påhlman, Sven and Larsson, Christer and Jirström, Karin and Bexell, Daniel and Leandersson, Karin}},
  issn         = {{0014-4827}},
  keywords     = {{Breast cancer; Endocrine resistance; Estrogen receptor; FOXO3a; Macrophage; TNFalpha}},
  language     = {{eng}},
  month        = {{05}},
  number       = {{1}},
  publisher    = {{Academic Press}},
  series       = {{Experimental Cell Research}},
  title        = {{Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells}},
  url          = {{http://dx.doi.org/10.1016/j.yexcr.2020.111932}},
  doi          = {{10.1016/j.yexcr.2020.111932}},
  volume       = {{390}},
  year         = {{2020}},
}